Alzamend Neuro (ALZN) P/E Ratio
P/E Ratio as of Jul 2, 2025: -0.11
Average-0.1182
Median-0.1100
Minimum-0.1400
Maximum-0.1100
-0.11
Past Month+0.03 (21.43%)
The P/E ratio for Alzamend Neuro (ALZN) is -0.11 as of Jul 2, 2025. This represents a decrease of -52.17% compared to its 12-month average P/E ratio of -0.23. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Alzamend Neuro P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Alzamend Neuro’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Alzamend Neuro to industry peers.
Alzamend Neuro P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Alzamend Neuro’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Alzamend Neuro to industry peers.
Alzamend Neuro (ALZN) P/E Ratio Insights
See Alzamend Neuro’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Alzamend Neuro (ALZN)
Order type
Buy in
Order amount
Est. shares
0 shares
Alzamend Neuro (ALZN) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jul 1, 2025 | $2.92 | -0.11 |
| Jun 2, 2025 | $3.50 | -0.13 |
| May 1, 2025 | $5.9859 | -0.22 |
| Apr 1, 2025 | $8.9559 | -0.32 |
| Mar 3, 2025 | $6.8004 | -0.25 |
| Feb 3, 2025 | $10.26 | -0.37 |
| Jan 2, 2025 | $10.80 | -0.18 |
Alzamend Neuro (ALZN) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -0.11 | -35.29% |
| 2024 | -0.17 | -55.26% |
| 2023 | -0.38 | -91.12% |
| 2022 | -4.28 | -98.47% |
| 2021 | -278.91 | — |
FAQs About Alzamend Neuro (ALZN) P/E ratio
The latest P/E ratio of Alzamend Neuro (ALZN) is -0.11, as of Jul 2, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Alzamend Neuro’s last 12-month average P/E ratio is -0.23, compared to its current P/E ratio of -0.11. This reflects a decrease of -52.17%.
Alzamend Neuro’s current P/E ratio of -0.11 is lower than its last 12-month average P/E of -0.23. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Alzamend Neuro’s average P/E ratio over the last 3 years is -2.2. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Alzamend Neuro’s average P/E ratio over the last 5 years is -103.81. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.